Earnings: Watch These 5 Stocks

 | Feb 07, 2017 11:01AM ET

h3 Gilead Sciences (NASDAQ:GILD)

Health Care - Biotechnology | Reports February 7, after the close.

The Estimize consensus is looking for earnings per share of $2.50, six cents above the sell-side consensus and 23% lower than the same period a year earlier. That estimate has decreased 11% since Gilead’s last quarterly report. Revenue is anticipated to decrease 15% to $7.2 billion, $50M above Wall Street.

What to Watch: Wednesday’s report will once again highlight the performance of new HIV and HBV products but above all else, the HCV franchise will draw most of the attention. In the third quarter, sales of Harvoni, Sovaldi and Epclusa fell to $3.3 billion compared to $4.8 billion from a year earlier. Management blamed the decline in Harvoni and Sovaldi sales on the introduction of Epclusa in key U.S. and European market but the more likely culprit is Merck's (NYSE:MRK) entry into the Hep C market. Merck’s aggressive pricing strategy stole a considerable amount of the Hep C market that Gilead once cornered.

Offsetting some of these losses was a strong performance from HIV and other antiviral products. Sales from the two jumped to $3.5 billion from $2.9 billion a year primarily due to an uptake in tenofovir alafenamide based products. This trend should provide some support in the fourth quarter as well. Gilead also recently launched its first HBV drug, Vemlidy, which should start to contribute meaningfully to the top line.

Besides the question of drug sales, Gilead face the threat that President Trump decimates drug pricing in the biotech and pharmaceutical industry. Any indication that financial performance will be hurt in fiscal 2017 from the new administration could ignite a sharp sell off Wednesday afternoon.

h3 Walt Disney Company (NYSE:DIS)
/h3

Consumer Discretionary - Media | Reports February 7, after the close.

The Estimize consensus is looking for earnings per share of $1.51, 4 cents above the Wall Street consensus and down 7% from the same period last year. That estimate has decreased 6% since Disney’s most recent report in October. Revenue is anticipated to come in at $15.3B, 1% higher than the year-ago results, and $50M higher than the sell-side’s consensus.

What to Watch: As always, ESPN subscription numbers fall front and center when Disney announces quarterly results. The multimedia sports network continues to face an uphill battle in light of cord-cutting behaviors and wider adoption of skinny bundles. Operating income from Cable Networks decreased $207 million during Q4 due to decreases at ESPN and Disney Channel. Growth at Freeform (formerly ABC Family) helped offset some of these losses through lower programming and production costs, and a decrease in marketing expenses. Income from broadcasting, on the other hand, increased $60 million to $224 million, on greater program sales from shows such as Luke Cage and Quantico. However, the overall performance of media networks is still predicated on the performance of ESPN, which otherwise looks bleak.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Beyond media, performance in Studio Entertainment and Parks and Resorts continues to excel on the back of blockbuster movies that also translate to attractions at the theme parks. Studio entertainment is likely to see a huge uptake in Q1 from the roaring success of Star War Rogue One. And while the economy improves and travel trends start to pick up that plays into the hands of Parks and Resorts. Both divisions posted positive growth in the fourth quarter and remain on track to do so again.

Disney also generates a large portion of total revenue from consumer products and interactive media which includes licensed merchandise. Sales from this division saw considerable pressure last quarter as revenue dropped 15% and income declined 5%. The company quickly pointed to currency headwinds and the discontinuation of the Infinity console game business for the lackluster performance. With the dollar trending close to a short term high, it’s unlikely Disney does a complete 180 this quarter.

h3 Whole Foods Market (NASDAQ:WFM)/h3

Consumer Staples - Food & Staples Retailing | Reports February 8, after the close.

The Estimize consensus calls for EPS of $0.41, 1 cent above the Wall Street consensus. Revenue expectations of $4.984 billion are in-line with the sell-side consensus. Expectations have decreased 7% since last quarter, putting YoY growth expectations at -9% for EPS and 3% for sales.